Teyi Pharmaceutical Group: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Teyi Pharmaceutical Group: Financial Report for the first half of 2024.
Teyi Pharmaceutical Group: Announcement Regarding the Delay of 2024 Interim Report Disclosure
Teyi Pharmaceutical Group: Announcement Regarding Share Repurchase: Shareholder holdings of top ten shareholders and top ten unrestricted shareholders with regards to share repurchase.
Teyi Pharmaceutical Group: Inspection opinions of Dongguan Securities Co., Ltd. on the use of convertible bonds partially idle raised funds to temporarily supplement working capital by Teyi Pharmaceutical Group Co., Ltd.
Teyi Pharmaceutical Group: Notice on Using Some Idle Funds Raised from Convertible Bonds to Temporarily Replenish Liquidity
Teyi Pharmaceutical Group: Announcement on winning the National May Day Labor Award
Teyi Pharmaceutical: Announcement on capital raised for early return and repayment of debt to temporarily supplement working capital
Teyi Pharmaceutical: Announcement on the early return of funds raised to temporarily supplement working capital by returning part of the convertible debt
Teyi Pharmaceutical: Announcement on the Appointment of Senior Executives
Teyi Pharmaceutical: Legal Opinion of Guohao Attorney (Shenzhen) Firm on the 2023 Annual General Meeting of Shareholders of Teyi Pharmaceutical Group Co., Ltd.
Teyi Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Teyi Pharmaceutical: Announcement on the resignation of the company's senior management
Teyi Pharmaceutical: Comparative table of amendments to the company's articles of association
Teyi Pharmaceutical: Announcement on changing the company's email
Teyi Pharmaceutical: 2023 Annual Financial Report
Teyi Pharmaceutical: Internal Control Self-Assessment Report
Teyi Pharmaceutical: 2023 Annual Shareholders' Meeting Information
Teyi Pharmaceutical: Notice of Annual General Meeting of Shareholders
Teyi Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
No Data
No Data